Diabetes and breast cancer are connected via the presence of hyperinsulinemia, inflammation caused by obesity, and changes in sex hormones. The present study investigated the ability of enriched fractions isolated from hemp (Cannabis sativa L. subsp.) to inhibit α-glucosidase and exhibit cytotoxic effects on Michigan Cancer Foundation-7 (MCF-7) and MD Anderson-metastatic breast-231 (MDA-MB-231) cells. The enriched fractions were found to include tetrahydrocannabinol, cannabidiol, phenolics, flavonoids, terpenoids, and alkaloids. The phytochemical compositions of the extracts were evaluated for their correlation with α-glucosidase inhibitory activities and their effects on MCF-7 and MDA-MB-231 cells. In the α-glucosidase inhibition studies, the α-glucosidase inhibitory activities (maltase and sucrase) of CL3 exhibited a greater inhibitory impact when compared with acarbose, with IC50 values of 3.36 ± 0.90 and 2.15 ± 0.17 mg/ml, respectively, with statistical significance (p < 0.05). The corresponding IC50 values were 2.15 ± 0.17 and 0.40 ± 0.09 mg/ml. According to a kinetic examination, intestinal maltase and sucrase were inhibited by CL3 in uncompetitive and noncompetitive manners. Cell viability assays after 24 hours of treatment of the cancer cells with enriched fractions using MTT were observed. Cancer cell proliferation was effectively inhibited by the enriched fraction at concentrations of 100–200 ppm, with statistical significance at the confidence level of p < 0.05. In addition, the results show that the high doses of CR5, CR6, CS7, and CS8 induced apoptosis. Our findings indicate that hemp has both anti-diabetic and anti-cancer capabilities, which might pave the way for future advancements in drug research.
Damsud T, Pothipongsa A, Saenjum C, Sichaem J. Anti-diabetes and anti-breast cancer of bioactive compounds-enriched fractions isolated from hemp (Cannabis sativa L. subsp.). J Appl Pharm Sci. 2024. Online First. http://doi.org/10.7324/JAPS.2024.657585
1. Zhu B, Qu S. The relationship between diabetes mellitus and cancers and its underlying mechanisms. Front Endocrinol. 2022;13:800995. https://doi.org/10.3389/fendo.2022.800995 | |
2. Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B. Diabetes mellitus and breast cancer. Lancet Oncol. 2005;6(2):103-11. https://doi.org/10.1016/S1470-2045(05)01736-5 | |
3. Jordt N, Kjærgaard KA, Thomsen RW, Borgquist S, Cronin-Fenton D. Breast cancer and incidence of type 2 diabetes mellitus: a systematic review and meta-analysis. Breast Cancer Res Treat. 2023;202(1):11-22. https://doi.org/10.1007/s10549-023-07043-6 | |
4. Chaachouaya N, Azerouala A, Bencharkia B, Douirab A, Zidaneb L. Cannabis sativa L.: a review on traditional uses, botany, phytochemistry, and pharmacological aspects. Trad Integrative Med. 2023;8(1):97-116. https://doi.org/10.18502/tim.v8i1.12407 | |
5. Malabadi RB, Kolkar KP, Chalannavar RK. Cannabis sativa: ethnobotany and phytochemistry. Int J Innov Sci Res Rev. 2023;5(2):3990-8. | |
6. Bautista JL, Yu S, Tian L. Flavonoids in cannabis sativa: biosynthesis, bioactivities, and biotechnology. ACS Omega. 2021;6(8):5119-23. https://doi.org/10.1021/acsomega.1c00318 | |
7. Kundan M, Gani U, Fayaz M, Angmo T, Kesari R, Rahul VP, et al. Two R2R3-MYB transcription factors, CsMYB33 and CsMYB78 are involved in the regulation of anthocyanin biosynthesis in Cannabis sativa L. Ind Crops Prod. 2022;188:115546. https://doi.org/10.1016/j.indcrop.2022.115546 | |
8. Watanakul P, Phattaralerphong J, Pitija K, Nakmee PS. Terpenoid profiling of Thai strain cannabis leaves (Cannabis sativa L. subsp. sativa) by Headspace (HS) couple with GC/MS. JoP. 2024;4(1):3-11. | |
9. Gary R, Trina H, Joshua AH, Joshua E, Brian H, Alexandros M. Cannabis sativa: an overview. Nutraceuticals. 2021;2:603-624. https://doi.org/10.1016/B978-0-12-821038-3.00038-0 | |
10. van Klinken BJ-W, Stewart ML, Kalgaonkar S, Chae L. Health-promoting opportunities of hemp hull: the potential of bioactive compounds. J Diet Suppl. 2024;1-15. https://doi.org/10.1080/19390211.2024.2308264 | |
11. Grafinger KE, Krönert S, Broillet A, Weinmann W. Cannabidiol and tetrahydrocannabinol concentrations in commercially available CBD E-liquids in Switzerland. Forensic Sci Int. 2020;310:110261. https://doi.org/10.1016/j.forsciint.2020.110261 | |
12. Thanakorn D, Pennapa R, Suntaree A, Chalermpong S, Mary AL. Effects of in vitro simulated gastrointestinal digestion on the α-glucosidase inhibitory activities of Thai folk remedies: synergistic effects with Acarbose. Trop J Nat Prod Res. 2023;7(12):5548-57. https://doi.org/10.26538/tjnpr/v7i12.26 | |
13. Rachpirom M, Ovatlarnporn C, Thengyai S, Sontimuang C, Puttarak P. Dipeptidyl peptidase-IV (DPP-IV) inhibitory activity, antioxidant property and phytochemical composition studies of herbal constituents of Thai folk anti-diabetes remedy. Walailak J Sci Technol. 2016;13(10):803-14. | |
14. Rangsinth P, Sharika R, Pattarachotanant N, Duangjan C, Wongwan C, Sillapachaiyaporn C, et al. Potential beneficial effects and pharmacological properties of ergosterol, a common bioactive compound in edible mushrooms. Foods. 2023;12(13):2529. https://doi.org/10.3390/foods12132529 | |
15. Nilkhet S. Anti-tumor activities of auricularia polytricha extracts in hepatocellular carcinoma cell line (HepG2) and breast cancer cell lines (MCF-7 AND MDA-MB-231). Bangkok, Thailand: Chulalongkorn University; 2019. | |
16. Nagy DU, Cianfaglione K, Maggi F, Sut S, Dall'Acqua S. Chemical characterization of leaves, male and female flowers from spontaneous Cannabis (Cannabis sativa L.) growing in Hungary. Chem Biodiv. 2019;16(3):e1800562. https://doi.org/10.1002/cbdv.201800562 | |
17. Damsud T, Tedphum T, Sukkrong C. Alternative protein-enriched food matrices with concentrated ripe mango (Mangifera indica L.) bioflavonoids for topical applications. Mater Today. 2021;43:2525-30. https://doi.org/10.1016/j.matpr.2020.04.612 | |
18. Doungwichitrkul T, Damsud T, Phuwapraisirisan P. α-glucosidase inhibitors from cold-pressed black sesame (Sesamum indicum) meal: characterization of new furofuran lignans, kinetic study, and in vitro gastrointestinal digestion. J Agric Food Chem. 2024;72(2):1044-54. https://doi.org/10.1021/acs.jafc.3c04159 | |
19. Yin Z, Zhang W, Feng F, Zhang Y, Kang W. α-Glucosidase inhibitors isolated from medicinal plants. Food Sci Hum Wellness. 2014;3(3-4):136-74. https://doi.org/10.1016/j.fshw.2014.11.003 | |
20. Suttithumsatid W, Shah MA, Bibi S, Panichayupakaranant P. α-Glucosidase inhibitory activity of cannabidiol, tetrahydrocannabinol and standardized cannabinoid extracts from Cannabis sativa. Curr Res Food Sci. 2022;5:1091-7. https://doi.org/10.1016/j.crfs.2022.07.002 | |
21. Jia M, Li Y, Xin H-L, Hou T-T, Zhang N-D, Xu H-T, et al. Estrogenic activity of osthole and imperatorin in MCF-7 cells and their osteoblastic effects in Saos-2 cells. Chin J Nat Med. 2016;14(6):413-20. https://doi.org/10.1016/S1875-5364(16)30037-1 | |
22. Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L, et al. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther. 2006;318(3):1375-87. https://doi.org/10.1124/jpet.106.105247 | |
23. Hermanson DJ, Marnett LJ. Cannabinoids, endocannabinoids, and cancer. Cancer Metastasis Rev. 2011;30(3-4):599-612. https://doi.org/10.1007/s10555-011-9318-8 | |
Year
Month